GLP-1 receptor agonistGLP-1 Agonists
Dulaglutide (Trulicity)
A once-weekly GLP-1 receptor agonist fused to an IgG4 Fc fragment for extended half-life. FDA-approved for type 2 diabetes. REWIND trial demonstrated cardiovascular benefit in patients with and without established CVD.
blood-sugar-controlweight-losscardiovascular-protectionFDA-approved
3D Structure
3D Structure
59670 Da
Molecular Weight59,670 Da
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
No mass spec data
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A once-weekly GLP-1 receptor agonist fused to an IgG4 Fc fragment for extended half-life. FDA-approved for type 2 diabetes. REWIND trial demonstrated cardiovascular benefit in patients with and withou…